Literature DB >> 35016593

Aminoacyl-tRNA Synthetases, Indispensable Players in Lung Tumorigenesis.

Pratyasha Bhowal1, Priyanka Biswas Karmakar1, Debkanya Dey1, Riya Manna1, Debraj Roy1, Rajat Banerjee1.   

Abstract

Being an essential enzyme in protein synthesis, the aminoacyl-tRNA synthetases (aaRSs) have a conserved function throughout evolution. However, research has uncovered altered expressions as well as interactions of aaRSs, in league with aaRS-interacting multi-functional proteins (AIMPs), forming a multi-tRNA synthetase complex (MSC) and divulging into their roles outside the range of protein synthesis. In this review, we have directed our focus into the rudimentary structure of this compact association and also how these aaRSs and AIMPs are involved in the maintenance and progression of lung cancer, the principal cause of most cancer-related deaths. There is substantial validation that suggests the crucial role of these prime housekeeping proteins in lung cancer regulation. Here, we have addressed the biological role that the three AIMPs and the aaRSs play in tumorigenesis, along with an outline of the different molecular mechanisms involved in the same. In conclusion, we have introduced the potentiality of these components as possible therapeutics for the evolution of new-age treatments of lung tumorigenesis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  AIMPs; Aminoacyl-tRNA synthetases (aaRSs); MSC; inhibitors; lung cancer; signal pathways

Mesh:

Substances:

Year:  2022        PMID: 35016593     DOI: 10.2174/0929866529666220110143520

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  1 in total

1.  High expression of DARS2 indicates poor prognosis in lung adenocarcinoma.

Authors:  Yingfeng Jiang; Jianbin You; Chuncai Wu; Yanli Kang; Falin Chen; Liangyuan Chen; Wenbing Wu
Journal:  J Clin Lab Anal       Date:  2022-09-09       Impact factor: 3.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.